Temple University Hospital at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Temple University Hospital brings 3 presentations to IDWeek 2026 in Washington. Its program spans HIV care, C. difficile testing and endocarditis. It covers long-acting injectable HIV treatment and prevention in practice, predictors of a positive C. difficile toxin test, and valve thickening as a sign of endocarditis in people who inject drugs.
| Organization | IDWeek 2026 Attendance |
|---|---|
Temple University Hospital Philadelphia, PA | |
Poster Fri Oct 23 12:15pm–1:30pm Real-World Implementation of Long-Acting Injectable Antiretroviral Therapy for HIV Treatment and Prevention: Adherence, Retention, and Outcomes Poster Fri Oct 23 12:15pm–1:30pm Risk Predictors for C. difficile Toxin-Positivity in Stool Samples Among Hospitalized Patients Poster Sat Oct 24 12:15pm–1:30pm The Plot Thickens: Association Between Valve Thickening on Echocardiogram and Infective Endocarditis (IE) in Persons who Inject Drugs (PWID) with Bacteremia |
Instantly find 20 buyers from Temple University Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction